Superconductivity and Cryogenics in Medical Diagnostics and Treatment: An Overview of Selected Applications

This article presents a comprehensive overview of the current and emerging roles of cryogenics and superconductivity in medical diagnostics, imaging, and therapy. Beginning with the historical foundations of both fields and their technological maturation, this review emphasizes how cryogenic engineering and superconducting materials have become indispensable to modern medical systems. Cryogenic technologies are highlighted in applications such as cryosurgery, cryotherapy, cryostimulation, and cryopreservation, all of which rely on controlled exposure to extremely low temperatures for therapeutic or biological preservation purposes. This article outlines the operating principles of cryomedical devices, the refrigerants and cooling methods used, and the technological barriers. This paper reviews the latest applications of superconductivity phenomena in medicine and identifies those that could be used in the future. These include cryogenic therapy, radiotherapy (cyclotrons, particle accelerators, synchrotron radiation generation, isotope production, and proton and ion beam delivery), magnetic resonance imaging (MRI), nuclear magnetic resonance spectroscopy (NMR), positron emission tomography (PET), and ultra-sensitive magnetic signal transducers based on SQUIDs for detecting ultra-low bio-signals emitted by human body organs. CT, MRI/NMR, and PET features are compared using the operation principle, specific applications, safety, contraindications for patients, examination time, and additional valued peculiarities. This article outlines the prospects for the development of superconducting and cryogenic materials and technologies in medical applications. Advances in diagnostic imaging are reviewed, with particular attention on the progression from conventional MRI scanners to ultra-high-field (UHF) systems exceeding 7–10.5 T, culminating in the 11.7 T Iseult whole-body MRI magnet. Another important application area described in this article includes biofunctionalized magnetic nanoparticles and superconducting quantum interference devices (SQUIDs), which enable the ultrasensitive detection of biomagnetic fields and targeted cancer diagnostics. Finally, this article identifies future directions of development in superconducting and cryogenic technologies for medicine.